Health-Related Quality of Life in Patients with Metastatic Basal Cell Carcinoma Treated with Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s337. https://doi.org/10.25251/skin.8.supp.337